Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative image analysis: software systems in drug development trials.

Sayan D Pathak1, Lydia Ng, Brad Wyman

  • 1Insightful Corporation, 1700 Westlake Ave. N, Suite 500, Seattle, WA 98109, USA. spathak@insightful.com

Drug Discovery Today
|June 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Connecting single-cell transcriptomes to projectomes in the mouse visual cortex.

Nature·2026
Same author

Whole-neuron morphology and genetic identity define cell types and reveal principles of brain-wide connectivity.

Cell reports·2026
Same author

A layered standards framework for integrating single-cell and spatial omics data into brain cell atlases.

bioRxiv : the preprint server for biology·2026
Same author

Genoarchitecture and input-output organization of the mouse basal ganglia and thalamic parafascicular nucleus.

Nature neuroscience·2026
Same author

<i>MapMyCells:</i> High-performance mapping of unlabeled cell-by-gene data to reference brain taxonomies.

bioRxiv : the preprint server for biology·2026
Same author

Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
Same journal

How many protein pairs can we chemically target?

Drug discovery today·2026
See all related articles

Advanced software for multi-dimensional image analysis aids drug development by automating lesion quantification in multiple sclerosis (MS) MRI scans, reducing user variability and improving efficiency.

Area of Science:

  • Medical image analysis
  • Radiology
  • Drug development

Background:

  • Multi-dimensional image analysis is crucial for surrogate endpoints in drug development.
  • Current methods for extracting imaging data are time-consuming and variable.
  • Advanced software systems are needed for automated medical image analysis in clinical trials.

Purpose of the Study:

  • To present a case study of a prototype system for quantifying multiple sclerosis lesions.
  • To demonstrate the utility of advanced software in medical image analysis for drug development.
  • To highlight the potential of automated segmentation and registration methods.

Main Methods:

  • Utilized a prototype software system for medical image analysis.
  • Employed multi-dimensional image analysis techniques on multivariate MRI data.

Related Experiment Videos

  • Focused on automated segmentation and registration for lesion quantification.
  • Main Results:

    • The prototype system demonstrated automated quantification of multiple sclerosis lesions.
    • The software facilitated quantitative extraction of anatomical features from MRI.
    • The system integrated data and results with audit trail generation.

    Conclusions:

    • Advanced software systems can automate and standardize medical image analysis for drug development.
    • The prototype system shows promise for accurate and efficient quantification of MS lesions.
    • Automated image analysis reduces user variability and enhances reliability in clinical trials.